SB 116 substantially revises Kentucky’s physician assistant licensure and practice framework. The bill replaces the older “supervising physician” model with a “collaborating physician” and “collaboration agreement” structure, clarifying that collaboration does not require the physician’s physical presence. It updates definitions, licensing standards, renewal requirements, disciplinary provisions, emergency permits, and the scope of practice for physician assistants. The measure also creates a nine-member Physician Assistant Advisory Committee to advise the Kentucky Board of Medical Licensure on licensing, renewals, discipline, and regulations.
The bill expands and modernizes physician assistant practice authority in several areas. It expressly allows physician assistants, under a collaboration agreement, to perform a broad range of medical services, initiate emergency treatment, prescribe nonscheduled legend drugs, and, with additional requirements, prescribe Schedule II through V controlled substances subject to detailed limits and registration requirements. It also adds collaboration-agreement requirements, including written scope-of-practice terms, communication procedures, signatures, recordkeeping, and a limit of four physician assistants per collaborating physician. Related amendments extend physician assistant authority into mental health and hospital settings, including qualifying as a “qualified mental health professional” in certain circumstances and performing hospital admission histories and physicals.
Beyond physician assistant law, SB 116 makes conforming changes in several other chapters to reflect the new collaboration model and to recognize physician assistants in additional contexts. These include mental health commitment statutes, child welfare definitions, hospital licensing rules, controlled-substance monitoring, and driver vision testing. The bill also updates Kentucky’s prescription monitoring system to cover controlled substances and medicinal cannabis, adds training and reporting requirements, and authorizes physician assistants and other clinicians to perform vision screening for driver licensing purposes if credentialed by the Transportation Cabinet.
The overall sentiment reflected in the bill’s legislative history appears strongly favorable. The measure passed the Senate and House with overwhelming margins, and it ultimately became law after being signed by the Governor. The vote totals suggest broad bipartisan support for the modernization of physician assistant practice and for the related public-health and administrative updates. No committee transcript excerpts were provided, so the available context does not show detailed floor or committee debate.
The main points of contention likely center on the shift away from direct physician supervision toward a collaboration-based model, the expanded prescriptive authority for physician assistants, and the limits placed on how many physician assistants a collaborating physician may work with. Other potentially sensitive issues include the bill’s incorporation of physician assistants into mental health certification, controlled-substance oversight, and cannabis monitoring, all of which involve patient safety, regulatory control, and professional scope-of-practice concerns.
SB 116 repeals KRS 311.854, 311.856, and 311.860 and rewrites the physician assistant chapter to replace supervision-based terminology with collaboration-based terminology. It changes how physician assistants are licensed, renewed, disciplined, and authorized to practice, while also creating new advisory and documentation requirements. The bill affects the Kentucky Board of Medical Licensure, physician assistants, collaborating physicians, hospitals, mental health facilities, and agencies involved in controlled-substance and medicinal cannabis monitoring.
The bill appears to have been viewed positively overall, with strong support in both chambers and final enactment into law. The large vote margins indicate broad agreement that Kentucky’s physician assistant laws needed modernization and that the bill’s public-health and regulatory provisions were acceptable to most legislators. The absence of recorded committee discussion in the provided materials limits more granular insight into objections or amendments.
The most notable policy tension is between expanding physician assistant autonomy and preserving physician oversight. Critics of scope expansion would likely focus on the move from supervision to collaboration, the ability to prescribe controlled substances, and the removal of statutory supervision provisions. Additional contention may arise from the bill’s limits on the number of physician assistants per collaborating physician, its use of physician assistants in mental health determinations, and the new reporting and monitoring requirements tied to controlled substances and medicinal cannabis.